In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Arda Ceylanİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0009-0004-7328-4291 Xiaozhou HuDepartment of Medical Biochemistry, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.
Tevfik Hatipoğluİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0001-9331-6749 Fenangi Chiara NainkwiDepartment of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0003-0115-9884 Kadriye Bahriye PayzınDepartment of Hematology, Faculty of Medicine, İzmir Katip Çelebi University, İzmir 35620, Türkiye.ORCID 0000-0001-7471-5453 Güner Hayri ÖzsanDepartment of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.
Itır Şirinoğlu DemirizDepartment of Internal Medicine, Faculty of Medicine, İstanbul Health and Technology University, İstanbul 34445, Türkiye.ORCID 0000-0001-7931-7104 Ömer ŞekerDepartment of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0002-0801-877X Merve KakçıDepartment of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.
Osman Can ÖztürkDepartment of Hematology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.
Bircan YılmazDepartment of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0002-5123-0194 Elif Yıldızİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0002-2919-5775 Athanasia Pavlopoulouİzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0002-0815-3808 Can KüçükDepartment of Medical Biology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Türkiye.ORCID 0000-0001-5540-9012 Funding
The Scientific and Technological Research Council of Türkiye 120S945The Scientific and Technological Research Council of Türkiye no: 120S945
6 · The paper itselfAbstract
Multiple myeloma (MM) is an incurable hematological malignancy.
Indexed as
Genes, Tumor SuppressorMultiple MyelomaSOXF Transcription FactorsApoptosisCell Line, TumorDNA MethylationGene Expression Regulation, NeoplasticHumansPanobinostatPromoter Regions, GeneticWnt Signaling PathwayPanobinostatSOX7 protein, humanSOXF Transcription FactorsChIP-Seqmultiple myelomapanobinostatSOX7tumor suppressor genewhole-transcriptome sequencingWnt/β-catenin pathway
Identifiers
PMID42737548
PMCPMC13566877
What OpenQuestion holds
Textmetadata
Read underepoch 390